RxDoctor Payments Data

Chander Arora

Internal Medicine · Marion, OHNPI 1316929094

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AstraZeneca at 33.0% of the total.

$568in general payments, 2019–2025

Across 55 payments — averaging $10.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$188
  • Pfizer$144
  • Grifols USA, LLC$32
  • Merck$30
  • Lilly USA, LLC$30
  • Supernus Pharmaceuticals, Inc.$25
  • plus $119 from 7 others
$139,097in research payments, 2019–2025

Across 78 payments — averaging $1783.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$109K
  • Akebia Therapeutics Inc$30K

What the payments were for

  • Food & beverage$568100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$568 in reported general payments places this provider in the 65th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio →

Other internal medicine in Marion

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →